GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2seventy bio Inc (MEX:TSVT) » Definitions » DeferredTaxAndRevenue

2seventy bio (MEX:TSVT) DeferredTaxAndRevenue : MXN16.3 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is 2seventy bio DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

2seventy bio's current deferred tax and revenue for the quarter that ended in Jun. 2024 was MXN16.3 Mil.

2seventy bio DeferredTaxAndRevenue Historical Data

The historical data trend for 2seventy bio's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

2seventy bio DeferredTaxAndRevenue Chart

2seventy bio Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
DeferredTaxAndRevenue
Get a 7-Day Free Trial 159.82 16.31 102.57 58.49 261.45

2seventy bio Quarterly Data
Dec18 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 216.73 226.90 261.45 271.12 16.27

2seventy bio DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of 2seventy bio's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


2seventy bio Business Description

Traded in Other Exchanges
Address
60 Binney Street, Cambridge, MA, USA, 02142
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.